Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay I Peters

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Annals of Internal Medicine|June 19, 2018
Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbationsDiego J Maselli, Jay I Peters
Annals of Internal Medicine|October 20, 2017
In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 monthsDiego J Maselli, Jay I Peters
Annals of Internal Medicine|April 5, 2013
ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPDSandra G Adams, Jay I Peters
Annals of Internal Medicine|September 18, 2013
5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbationDiego J Maselli, Jay I Peters
Current Opinion in Pulmonary Medicine|December 14, 2004
Long-acting beta(2)-agonists in the management of asthma exacerbationsMaria Angela C Hospenthal, Jay I Peters
Journal of Bronchology & Interventional Pulmonology|July 14, 2015
Iatrogenic Endobronchial Bleeding: Speed Things Up or Cool It Down?Scott Oh, Jay I Peters, Erik Folch
Therapeutics and Clinical Risk Management|November 15, 2018
Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid useDiego Jose Maselli, Linda Rogers, Jay I Peters
International Journal of Pharmaceutics|September 20, 2020
Corrigendum to "Inhaled nanoparticles-An updated review" [Int. J. Pharm. 587 (2020) 119671]Tuangrat Praphawatvet, Jay I Peters, Robert O Williams
International Journal of Pharmaceutics|March 25, 2008
Inhaled nanoparticles--a current reviewWei Yang, Jay I Peters, Robert O Williams
International Journal of Pharmaceutics|July 24, 2020
Inhaled nanoparticles-An updated reviewTuangrat Praphawatvet, Jay I Peters, Robert O Williams
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Annals of Internal Medicine|June 19, 2018
Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbationsDiego J Maselli, Jay I Peters
Annals of Internal Medicine|October 20, 2017
In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 monthsDiego J Maselli, Jay I Peters
Annals of Internal Medicine|April 5, 2013
ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPDSandra G Adams, Jay I Peters
Annals of Internal Medicine|September 18, 2013
5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbationDiego J Maselli, Jay I Peters
Current Opinion in Pulmonary Medicine|December 14, 2004
Long-acting beta(2)-agonists in the management of asthma exacerbationsMaria Angela C Hospenthal, Jay I Peters
Journal of Bronchology & Interventional Pulmonology|July 14, 2015
Iatrogenic Endobronchial Bleeding: Speed Things Up or Cool It Down?Scott Oh, Jay I Peters, Erik Folch
Therapeutics and Clinical Risk Management|November 15, 2018
Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid useDiego Jose Maselli, Linda Rogers, Jay I Peters
International Journal of Pharmaceutics|September 20, 2020
Corrigendum to "Inhaled nanoparticles-An updated review" [Int. J. Pharm. 587 (2020) 119671]Tuangrat Praphawatvet, Jay I Peters, Robert O Williams
International Journal of Pharmaceutics|March 25, 2008
Inhaled nanoparticles--a current reviewWei Yang, Jay I Peters, Robert O Williams
International Journal of Pharmaceutics|July 24, 2020
Inhaled nanoparticles-An updated reviewTuangrat Praphawatvet, Jay I Peters, Robert O Williams
Pageof 8